HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

17-Methyl-5alpha-androstane-3beta,17beta-diol

HCID 101819
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
641-83-8
Standard SMILES
C[C@]12CC[C@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O
InChIKey
QGKQXZFZOIQFBI-UYEYMFBJSA-N
Molecular formula
C20H34O2
Average molar mass
306.5 g/mol
Monoisotopic mass
306.25588032

Overview

17alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane is a DEA Schedule III controlled substance. Substances in the DEA Schedule III have a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence. It is a Anabolic steroids substance.

Names & identifiers

Preferred name
17-Methyl-5alpha-androstane-3beta,17beta-diol
IUPAC
(3S,5S,8R,9S,10S,13S,14S,17S)-10,13,17-trimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthrene-3,17-diol
English name
17-methyl-5alpha-androstane-3beta,17beta-diol
Molecular formula
C20H34O2
Molecular weight
306.48

Names & synonyms

641-83-817-Methyl-5alpha-androstane-3beta,17beta-diolUNII-ZA9UE4Q47VNSC 11817517Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstaneEINECS 211-377-85.alpha.-Androstane-3.beta.,17.beta.-diol, 17-methyl-Androstane-3,17-diol, 17-methyl-, (3.beta.,5.alpha.,17.beta.)-NSC-11817517.alpha.-Methyl-5.alpha.-androstane-3.beta.,17.beta.-diol5alpha-Androstane-3beta,17beta-diol, 17-methyl-17alpha-Methyl-5alpha-androstane-3beta,17beta-diol
Show more names
17-Methyl-5α-androstane-3β,17β-diol17 A ETHYL A ANDROSTANE-3B,17B-DIOL5α-ANDROSTAN-17α-METHYL-3β, 17β-DIOLAndrostane-3,17-diol, 17-methyl-, (3β,5α,17β)-(3S,5S,8R,9S,10S,13S,14S,17S)-10,13,17-trimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthrene-3,17-diol
17-METHYL-ANDROST-4-ENE-3.BETA.,17.BETA.-DIOL17.ALPHA.-METHYLANDROSTAN-3.BETA.-17.BETA.-DIOLAndrostane-3,17-diol, 17-methyl-, (3beta,5alpha,17beta)-17-METHYL-5.ALPHA.-ANDROSTANE-3.BETA.,17.BETA.-DIOL17.ALPHA.-METHYLANDROST-4-ENE-3.BETA.,17.BETA.-DIOL17.ALPHA.-METHYL-5.ALPHA.-ANDROSTAN-3.BETA.,17.BETA.-DIOL5.ALPHA.-ANDROSTANE-17.ALPHA.-METHYL-3.BETA.,17.BETA.-DIOL17.ALPHA.-METHYL-17.BETA.-HYDROXY-5.ALPHA.-ANDROSTAN-3.BETA.-OL

Properties

Computed structural properties

XLogP
4.3
Topological polar surface area
40.5 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
2
Rotatable bonds
0
Heavy atoms
22
Formal charge
0
Complexity
463

Experimental & physicochemical properties

DrugsDEA Schedule III Controlled Substance -> Anabolic steroids
Endocrine DisruptorsPotential endocrine disrupting compound

Physicochemical properties

Melting point
206 · 206-209 °C
Boiling point
418.1 · 418.1±18.0 °C(Predicted)
Density
1.069 · 1.069±0.06 g/cm3(Predicted)
pka
15.12 · 15.12±0.70(Predicted)
FDA UNII
9 UE4Q47V · ZA9UE4Q47V
Symbol(GHS)
8 · GHS08,GHS07
Signal word
Danger
Hazard statements
335 · H335-H360-H302+H312+H332-H315-H319
Precautionary statements
264 · P264-P280-P302+P352-P321-P332+P313-P362-P264-P280-P305+P351+P338-P337+P313P
DEA Controlled Substances
4000 CSA · CSCN: 4000CSA SCH: Schedule IIINARC: No

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H302+H312+H332 (100%): Harmful if swallowed, in contact with skin or if inhaled [Warning Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation]

P203, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P318, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Hazard information

Regulatory InformationDEA schedule III controlled substance
Hazard Classes and CategoriesAcute Tox. 4 (100%)

Safety data

Signal word
Danger
Symbol(GHS)
GHS08,GHS07
Hazard statements
H335-H360-H302+H312+H332-H315-H319
Precautionary statements
P264-P280-P302+P352-P321-P332+P313-P362-P264-P280-P305+P351+P338-P337+P313P
DEA Controlled Substances
CSCN: 4000CSA SCH: Schedule IIINARC: No

Chemistry & industry

Applications

UsesA metabolite of 17α-Methyltestosterone (M326400).

Upstream & downstream products

Upstream raw materials

Hecogenin

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
641-83-8
PubChem CID
101819
DTXSID
DTXSID801289130
UNII
ZA9UE4Q47V
EC Number
211-377-8
Nikkaji
J205.917G